6bK TFA is a selective insulin-degrading enzyme ( IDE ) inhibitor with an IC 50 of 50 nM. 6bK TFA binds to the distal pocket of IDE , thereby blocking substrate binding, peptide unfolding and cleavage processes, and reducing the degradation of insulin , glucagon and amylin. 6bK TFA improves oral glucose tolerance but impairs intraperitoneal glucose tolerance. 6bK TFA can be used in research related to type 2 diabetes.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Glucose Metabolism | Products > Disease Areas > Type 2 Diabetes | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > IDE
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.